ArticleAnnals of translational medicine2019

Co-expression of CD44/MyD88 is a poor prognostic factor in advanced epithelial ovarian cancer.

Yi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.